P765: UPDATED ENROLLMENT AND RESULTS FROM THE PHASE 1 SUBSTUDY OF IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME (R/R MDS)
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 660-661
10.1097/01.hs9.0000845944.18977.d1